ADMA BIOLOGICS INC's ticker is and the CUSIP is 000899904. A total of 4 filers reported holding ADMA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113,486 | -90.3% | 31,700 | -90.0% | 0.00% | -100.0% |
| Q2 2023 | $1,167,147 | +160.0% | 316,300 | +133.3% | 0.00% | +100.0% |
| Q1 2023 | $448,836 | -82.4% | 135,600 | -79.4% | 0.00% | -66.7% |
| Q4 2022 | $2,549,160 | +76.8% | 657,000 | +10.7% | 0.01% | +100.0% |
| Q3 2022 | $1,442,000 | +98.3% | 593,600 | +61.6% | 0.00% | +200.0% |
| Q2 2022 | $727,000 | +138.4% | 367,400 | +120.8% | 0.00% | – |
| Q1 2022 | $305,000 | +5.2% | 166,400 | -19.1% | 0.00% | – |
| Q4 2021 | $290,000 | +18.9% | 205,800 | -4.5% | 0.00% | – |
| Q3 2021 | $244,000 | -41.3% | 215,500 | -17.0% | 0.00% | -100.0% |
| Q2 2021 | $416,000 | -48.5% | 259,700 | -43.3% | 0.00% | 0.0% |
| Q1 2021 | $807,000 | +44.9% | 458,300 | +60.5% | 0.00% | 0.0% |
| Q4 2020 | $557,000 | -44.4% | 285,500 | -31.9% | 0.00% | -66.7% |
| Q3 2020 | $1,002,000 | -0.3% | 419,400 | +22.3% | 0.00% | -40.0% |
| Q2 2020 | $1,005,000 | -9.5% | 343,000 | -11.1% | 0.01% | -44.4% |
| Q1 2020 | $1,111,000 | +1849.1% | 385,700 | +2597.2% | 0.01% | – |
| Q4 2019 | $57,000 | -78.7% | 14,300 | -76.1% | 0.00% | -100.0% |
| Q3 2019 | $267,000 | +345.0% | 59,900 | +289.0% | 0.00% | +100.0% |
| Q2 2019 | $60,000 | – | 15,400 | +15300.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 100 | -90.0% | 0.00% | – |
| Q4 2018 | $2,000 | -60.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 135,600 | $448,836 | 0.00% |
| SIMPLEX TRADING, LLC | 268,500 | $888 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 98,600 | $326,366 | 0.00% |